Evidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.
Although Cuba reported no cases of Zika virus in 2017 and 2018, investigators used travel data and genomic epidemiology to uncover a large, “hidden” Zika outbreak.
As the leading cause of unplanned 30-day hospital readmissions, sepsis affects more than 1.5 million individuals each year.
Epidemiologic and clinical lessons for the uninitiated.
Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Adriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.
Infectious diseases clinicians turn to Twitter as a tool for education and collaboration.
When the CD4 count seems too good to be true.
As of October 31, 2018, the CDC has reported 457 clinical cases of confirmed C auris infection with a majority in New York (>50%), New Jersey, and Illinois.
A review of the current literature and future directions.
Dr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.
Candida auris—Are we prepared for another multidrug-resistant pathogen?
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.
Frontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.
Hospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.
This In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.
Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.
Early diagnosis and treatment were essential to ensuring a good prognosis.
A novel NNRTI hits the market, but what place will it have in treatment?
As the population of people living with HIV infection is living longer, age-related health issues are affecting these individuals in an accelerated or emphasized fashion.
Here is a brief report of 5 cases of the use of fecal microbiota, live-jslm (Rebyota) in the management of recurrent Clostridioides difficile infection.
Aerosolized antibiotics are a reasonable adjunctive option to treat multidrug-resistant gram-negative pneumonia due to excellent pulmonary concentrations and few adverse effects.
A shocking find on a CT scan leads to an unexpected diagnosis.
A case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.